• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Exits

Enterprise reaps 10x on Magellan

Rising stock in Poland
  • Kimberly Romaine
  • 15 April 2013
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

CEE investor Enterprise Investors makes 10x on share sale of Magellan, 10 years after backing the business. The returns come just a week after the GP made 9x on Kruk.

Enterprise Investors has further reduced its stake in Polish healthcare financial institution Magellan via a secondary share sale on the Warsaw Stock Exchange. The deal sees Enterprise sell 33.79% of its shares, or 2,211,250 shares, bringing its share in the company down to 33.79%. The shares were sold at PLN 52 each, a sizable increase on the PLN 42 per share achieved at the 2007 IPO and near the stock's 52-week high of PLN 54.

The Magellan deal marks a partial exit for Enterprise's Polish Enterprise Fund IV.

Previous funding
The firm initially backed Magellan 10 years ago when it participated in an $8m capital increase. It went on to wholly acquire the business when it bought out the company's founder.

Enterprise partially exited Magellan in a Warsaw flotation in October 2007. That transaction yielded gross proceeds of $13.5m for the fund, representing a 10x multiple of the original investment cost and 67% IRR in US dollars, according to unquote" data. Magellan also raised almost $7m in the float to finance the growth of its loan portfolio. 1,300,000 shares were offered at a price of PLN 42 per share, and the company debuted at a 7% increase over the offer price. The IPO was three times oversubscribed in the institutional investors' tranche. Magellan's market capitalisation as of the exit date was €76m. The IPO represented 20% of Magellan's capital; the management retained 4% and Enterprise retained the remaining 76%.

Magellan

  • DEAL:

    IPO - secondary sale

  • LOCATION:

    Lódz

  • SECTOR:

    Speciality finance

  • FOUNDED:

    1999

  • TURNOVER:

    $33.6m

  • STAFF:

    100+

  • VENDOR:

    Enterprise Investors

  • RETURNS:

    10x

unquote" was advised on returns figures by LPs in Enterprise's funds; Enterprise themselves declined to comment.

Company
Founded in 1999, Lódz-based Magellan is a non-banking financial institution specialised in servicing the healthcare sector. It buys the outstanding debt of public healthcare units from primary creditors at a discount and then restructures and collects the debt for a profit. Hospitals and their suppliers constitute the customer base of the company. The solutions offered include financing of receivables, refinancing of liabilities, loans, guarantees, factoring, instalment schemes, lease and non-standard projects.

At the time of the IPO, Magellan had a core team of 30 employees; today it employs more than 100. The company's net profit reached approximately $2.3m in mid-2007; it stood at PLN 33.3m ($10.6m) for 2012. The company's turnover was PLN 24m (€6.5m) in 2006 and was PLN 105.6m ($33.6m) in 2012.

People
Dariusz Pronczuk, managing partner at Enterprise Investors, is responsible for the investment. Krzysztof Kawalec is chairman of the management board.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Exits
  • Financials
  • CEE
  • Enterprise Investors
  • Poland
  • Top story

More on Exits

Public sector software
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • Exits
  • 04 September 2023
Lender taking the keys from a sponsor
Ares Management handed keys to two-thirds of UK sponsor’s portfolio

Lender provided GBP 500m for three of the GP's deals between 2016 and 2019, Debtwire reported

  • Financing
  • 30 August 2023
Luggage and airport services
Actera Group explores strategic options for Celebi Ground Handling

Several investors placed bids for the company in 2022 but mismatch in pricing didn't lead to a deal

  • Exits
  • 30 August 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013